{"id":"placebo-transdermal-one-90-l-spray","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations serve as inactive comparators in randomized controlled trials to establish the efficacy and safety of investigational drugs by accounting for natural disease progression and psychological effects. This particular placebo is administered as a 90 μL transdermal spray, matching the delivery method of the active comparator drug being studied in the phase 3 trial.","oneSentence":"A placebo transdermal spray that delivers no active pharmaceutical ingredient, used as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:08.581Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01389102","phase":"PHASE3","title":"Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms","status":"COMPLETED","sponsor":"Lumara Health, Inc.","startDate":"2004-12","conditions":"Hot Flashes","enrollment":454}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo transdermal one 90 μL spray","genericName":"Placebo transdermal one 90 μL spray","companyName":"Lumara Health, Inc.","companyId":"lumara-health-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}